North America Orthobiologics Market Forecast 2017-2025
KEY FINDINGS The North America orthobiologics market is expected to grow at $5193 million by 2025. The market growth is anticipated at the CAGR of 6.94% in the forecast period. The base year deliberated for the study of the orthobiologics market is 2016. The rise in the orthobiologics material and increasing demand for spinal fusion surgeries are driving the orthobiologics market in North America region.
MARKET INSIGHTS The North America orthobiologics market is segmented on the basis of product, application, end-user, and geography. The North America market of orthobiologics by product is further segmented into the demineralized bone matrix (DBM), Bone morphogenetic protein (BMP), viscosupplementation, synthetic bone graft substitutes, stem cell therapy and others products market. The application segment is further classified into spinal fusion, trauma repair, and reconstructive surgery, tendon and ligament repair market and other application market. The market by end-user is segmented into hospital market and clinics market. The North America orthobiologics market by geography is further segmented into United States, Canada. Increasing products of orthobiologics leading the growth of orthobilogics market in North America region.
COMPETETIVE INSIGHTS Major players for the Orthobiologics market are Bioventus, DePuy Inc. (Acquired by Johnson and Johnson), Exatech Inc., Globus Medical Inc., Integra Life sciences Holding Corporation, Johnson& Johnson, Medtronic Inc., Nuvasive Inc., RTI Surgical, Sanofi, Stryker Corporation, Zimmer Biomet Inc., and Mölnlycke Health Care AB.